Skip to content

12 Lead ECG Database

12-Lead ECG Database

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06513637
Enrollment
150
Registered
2024-07-22
Start date
2024-07-19
Completion date
2025-12-31
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac

Brief summary

The purpose of this investigation is to collect a database of simultaneous electrocardiogram (ECG) recordings from the SANSA device and a reference 12-lead ECG recording device. The purpose of this database is to aid development and evaluation of algorithms to detect cardiac arrhythmias and other parameters from the electrocardiogram. Example analyses that may utilize this database are ECG vector transformations and ECG waveform timing analyses. The study is for scientific purposes and does not intend to diagnose, cure, mitigate, treat, or prevent any disease and does not involve any medical procedures.

Interventions

DIAGNOSTIC_TEST12-Lead ECG and home sleep study (HST) diagnostics

* 12-lead ECG hookup will be performed following standard placement procedures. * The Home Sleep Study diagnostic device placement will be performed by study personnel following the manufacturer's instructions.

Sponsors

Huxley Medical, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* are 18 years of age or older. * are able to read, understand, and sign informed consent documentation. * are willing to undergo simultaneous recordings with the Sansa and 12-lead ECG device.

Exclusion criteria

* exhibit deformities of the chest (e.g., pronounced scarring, pectus carinatum) that would interfere with sensor placement * have broken or injured skin that would interfere with sensor placement * are known to experience adverse reactions to medical-grade adhesive * are pregnant

Design outcomes

Primary

MeasureTime frameDescription
No specified primary endpointSubjects will participate in a single visit. Subjects will be considered enrolled upon signing the informed consent. The entire duration of enrollment is expected to be less than one hour and no more than six hoursThis data collection protocol does not have any specific data analysis endpoints. Its purpose is to collect data to be included in an ECG database that may be used for various future analyses. The number, severity, and device/comparator relatedness of AEs reported while subjects undergo study procedures will be reported.

Contacts

Primary ContactJill Fricke, BS
jill.fricke@huxleymed.com1-888-726-7239
Backup ContactBrennan Torstrick, PhD
brennan@huxleymed.com1-888-726-7239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026